|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
![]() Sponsored by: The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 101-125 out of 1136. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>
Public Release: 14-Nov-2012
Research breakthrough could halt melanoma metastasis In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 (mda-9)/syntenin. Contact: John Wallace Public Release: 14-Nov-2012
Enhancing breast cancer detection Straightforward imaging with an infrared, thermal, camera for detecting breast cancer early without the discomfort or inconvenience of mammography or biomolecular tests, according to a study to be published in the International Journal of Innovative Computing and Applications. Contact: Albert Ang Public Release: 14-Nov-2012
Cancer therapy -- Nanokey opens tumors to attack There are plenty of effective anticancer agents around. The problem is that, very often, they cannot gain access to all the cells in solid tumors. A new gene delivery vehicle may provide a way of making tracks to the heart of the target. Contact: Kathrin Bilgeri Public Release: 14-Nov-2012
Heart failure in older breast cancer patients linked to medication Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab, Yale School of Medicine researchers report in the current issue of the Journal of the American College of Cardiology. Contact: Karen N. Peart Public Release: 14-Nov-2012
Rare parasitic fungi could have anti-flammatory benefits Scientists at The University of Nottingham have discovered that a rare parasitic fungus that lives on hibernating caterpillars in Tibet could have a role to play in anti-inflammatory drugs for conditions such as asthma. Contact: Lindsay Brooke Public Release: 13-Nov-2012
A sip of resveratrol and a full p53: Ingredients for a successful cell death Researchers at the Universidade Federal in Rio de Janeiro in Brazil have found that introduction of a normal copy of the p53 gene in p53-defective cancer cell lines makes these cells sensitive to the anti-tumor proprieties of resveratrol, the naturally occurring dietary compound found in red wine. Contact: Jerson Lima Silva Public Release: 13-Nov-2012
Scientists discover how stomach cancer spreads Scientists at the University of Liverpool have found that the production of a protein that prevents the growth and spread of cancerous cells is impaired in patients with gastric cancer. Contact: Samantha Martin Public Release: 13-Nov-2012
Stereoscopic mammography could reduce recall rate A new three-dimensional digital mammography technique has the potential to significantly improve the accuracy of breast cancer screening. Contact: Linda Brooks Public Release: 13-Nov-2012
Effects of alcohol on lymphoma, leukemia, and other types of hematological cancers Diseases associated with the lymphatic system can be separated from those of the myeloid system. Contact: Helena Conibear Public Release: 13-Nov-2012
Cancer: Exercise reduces tiredness Aerobic exercise can help relieve the fatigue often associated with cancer and cancer treatment, according to Cochrane researchers. Their updated systematic review strengthens findings from an earlier version on cancer-related fatigue published in the Cochrane Library Contact: Ben Norman Public Release: 13-Nov-2012
Terminally ill cancer patients who discuss end-of-life care early can avoid aggressive treatment Terminally ill cancer patients who have an early talk with their physician about care at the end-of-life are less likely to receive aggressive therapy – and more likely to enter hospice care – than patients who delay such discussions until the days and weeks before death, a new study by Dana-Farber Cancer Institute researchers suggests. Contact: Anne Doerr Public Release: 13-Nov-2012
Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease? Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial tumor site. Contact: Vicki Cohn Public Release: 13-Nov-2012
Ancient foot massage technique may ease cancer symptoms A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology – a type of specialized foot massage practiced since the age of pharaohs – can help cancer patients manage their symptoms and perform daily tasks. Contact: Andy McGlashen Public Release: 13-Nov-2012
Injectable sponge delivers drugs, cells, and structure Bioengineers at Harvard have developed a gel-based sponge that can be molded to any shape, loaded with drugs or stem cells, compressed to a fraction of its size, and delivered via injection. Once inside the body, it pops back to its original shape and gradually releases its cargo, before safely degrading. Contact: Caroline Perry Public Release: 13-Nov-2012
For brain tumors, origins matter Since stem cells and progenitor cells are regulated by different growth factors, brain tumors arising from these cells might respond differently to different therapies. Researchers at Sanford-Burnham Medical Research Institute found that basic fibroblast growth factor (bFGF) induces stem cell growth, but inhibits neuronal progenitor growth. bFGF also blocks the growth of tumors that originate from progenitors. This study suggests bFGF-like molecules might be used to treat medulloblastoma -- but only tumors with the appropriate origins. Contact: Heather Buschman, Ph.D. Public Release: 13-Nov-2012
Stem cell finding could advance immunotherapy for lung cancer A University of Cincinnati Cancer Institute lung cancer research team reports that lung cancer stem cells can be isolated -- and then grown -- in a preclinical model, offering a new avenue for investigating immunotherapy treatment options that specifically target stem cells. Contact: Amanda Harper Public Release: 13-Nov-2012
Study demonstrates that earlier end of life care discussions are linked to less aggressive care in final days of life Summary of a study being published online Nov. 13, 2012 in the Journal of Clinical Oncology, reporting that earlier discussions about end of life care preferences are strongly associated with less aggressive care in the last days of life and increased use of hospice care for patients with advanced cancer. Contact: Amanda Narod Public Release: 13-Nov-2012
Targeting downstream proteins in cancer-causing pathway shows promise in cell, animal model The cancer-causing form of the gene Myc alters the metabolism of mitochondria, the cell's powerhouse, making it dependent on the amino acid glutamine for survival. Depriving cells of glutamine selectively induces programmed cell death in cells overexpressing mutant Myc. Using Myc-active neuroblastoma cells, a team three priotein executors of the glutamine-starved cell, representing a downstream target at which to aim drugs. Roughly 25 percent of all neuroblastoma cases are associated with Myc-active cells. Contact: Karen Kreeger Public Release: 12-Nov-2012
Scientists at IRB BARCELONA discover a key process that allows colon cancer to metastasize Researchers at the IRB Barcelona have determined that the ability of colon cancer to metastasize lies in the healthy cells, called stroma, that surround the tumor. Although the stroma has long been hypothesized to be complicit in this process, this study marks the first time that healthy cells in the microenvironment have been observed to play a fundamental role in allowing metastasis to occur in a specific tumor type. Contact: Sònia Armengou Public Release: 12-Nov-2012
New statistical method offers automatic mitotic cell detection for cancer diagnosis Scientists have developed a statistical image analysis method which can assist in the grading of breast cancer by automatically segmenting tumour regions and detecting dividing cells in tissue samples. Contact: Anna Blackaby Public Release: 12-Nov-2012
Place in the sun carries risks for outdoor workers Those individuals who work outdoors with resultant sun exposure are at increased risk for non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma. Manige Fartasch shows that the connection between occupational UV exposure and squamous cell carcinoma is now well-established in her review article in issue 43 of Deutsches Arzteblatt International. Contact: Manigé Fartasch Public Release: 12-Nov-2012
UT Arlington physics team demonstrates new power generation technique University of Texas at Arlington and Louisiana Tech University researchers created a hybrid nanomaterial that can be used to convert light and thermal energy into electrical current. The team built a prototype thermoelectric generator they hope can eventually produce milliwatts for use in devices such as self-powering sensors, low-power electronic devices and implantable biomedical micro-devices, they said. UT Arlington's Wei Chen has also coupled gold nanoparticles with copper sulfide nanoparticles for potential use in cancer therapy. Contact: Traci Peterson Public Release: 12-Nov-2012
Gene sequencing project identifies abnormal gene that launches rare childhood leukemia Research led by the St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis. Contact: Summer Freeman Public Release: 12-Nov-2012
Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation In the first broad genetic landscape mapped of a Burkitt lymphoma tumor, scientists at Duke Medicine and their collaborators identified 70 mutations, including several that had not previously been associated with cancer and a new one that was unique to the disease. Contact: Sarah Avery Public Release: 12-Nov-2012
PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers PI3-kinase inhibitors sensitized tumors to PARP inhibitors. Combination significantly prolonged progression-free survival in mouse model. Contact: Jeremy Moore
Showing releases 101-125 out of 1136. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>
|
Search News Releases
|
|||||||||||||||||||||||||